Skip to main content
Equibles

Swiss National Bank

Bank

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1582202 ZURICH, V8
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$5,873,280
+$732,488 QoQ
Shares Held
224,000
+2.7% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 271 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. ARQT ranks #50 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in ARQT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,873,280 224,000
2026-03-31 $5,140,792 218,200
2025-12-31 $6,179,712 212,800
2025-09-30 $3,918,915 207,900
2025-06-30 $2,860,080 204,000
2025-03-31 $3,190,560 204,000
2024-12-31 $2,882,117 206,900
2024-09-30 $1,893,480 203,600
2024-06-30 $1,893,480 203,600
2023-09-30 $537,372 101,200
2023-06-30 $877,713 92,100
2023-03-31 $1,013,100 92,100
2022-12-31 $1,505,160 101,700
2022-09-30 $1,868,958 97,800
2022-06-30 $1,517,272 71,200
2022-03-31 $1,145,970 59,500
2021-12-31 $1,144,848 55,200
2021-09-30 $1,318,728 55,200
2021-06-30 $1,506,408 55,200
2021-03-31 $1,625,866 56,200
2020-12-31 $683,559 24,300
2020-09-30 $624,090 21,300
2020-06-30 $644,112 21,300